知镜 Cognispect · 医学文献与研究工作台

Diagnostic Accuracy of a Novel Chemiluminescent Immunoassay for Strongyloides stercoralis in a Non-Endemic Clinical Setting.

Roose S, Sanfilippo L, Tais S, Negrelli S, Rizzi E, Gambini G, Tamarozzi F, Perandin F, Buonfrate D.
Diagnostics (Basel, Switzerland) · 2026-10-06 · PMID 42882382

文献摘要

Background/Objectives: Strongyloides stercoralis is a soil-transmitted helminth that can cause severe disease in immunocompromised individuals. In non-endemic clinical settings, recommended diagnostic strategies rely on serology alone or in combination with a sensitive fecal test, maximizing sensitivity to avoid missed infections. The S. stercoralis VirClia ® IgG monotest (Vircell, Spain) is a novel automated chemiluminescent immunoassay (CLIA) that detects IgG antibodies against the recombinant NIE and SsIR antigens. This study evaluated its diagnostic accuracy (sensitivity and specificity) in a non-endemic clinical setting. Methods: In this monocentric retrospective study, 245 serum samples from the Tropica Biobank of a referral centre for parasitic diseases in Italy were analyzed. Samples originated from individuals from Africa (n = 85), America (n = 31), Asia (n = 53), and Europe (n = 76). Diagnostic accuracy was estimated using Bayesian latent class analysis based on a model including five routinely used diagnostic tests. Results: The S. stercoralis VirClia ® IgG monotest showed a sensitivity of 95.0% (95% credible interval [CrI]: 90.1-98.2%) and a specificity of 90.8% (95% CrI: 85.1-96.0%) for the tested population. Conclusions: In immunocompetent individuals with a risk of previous exposure to S. stercoralis , the S. stercoralis VirClia ® IgG monotest showed high diagnostic accuracy. Its high sensitivity supports current recommendations favouring highly sensitive serological assays for screening and diagnosis in non-endemic clinical settings.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。